Benzinga | Nov 9, 2020 08:27AM EST

Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $130

Morgan Stanley maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $110 to $130.